HK Stock MarketDetailed Quotes
01093 CSPC PHARMA
- 6.710
- +0.230+3.55%
Market Closed May 2 16:08 CST
80.00BMarket Cap12.33P/E (TTM)
6.740High6.440Low25.64MVolume6.500Open6.480Pre Close170.67MTurnover0.22%Turnover Ratio12.33P/E (Static)11.92BShares7.89052wk High2.18P/B80.00BFloat Cap5.20052wk Low0.25Dividend TTM11.92BShs Float12.999Historical High0.210Dividend LFY4.63%Amplitude-1.499Historical Low6.656Avg Price2000Lot Size3.73%Div YieldTTM3.13%Div Yield LFY
CSPC PHARMA Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -2.54%7.39B | ---- | 10.74%7.58B | ---- | 7.14%6.85B | ---- | 38.15%6.39B | ---- | 21.99%4.63B | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -0.40%-259.88M | ---- | -34.65%-258.84M | ---- | -67.54%-192.22M | ---- | -77.22%-114.73M | ---- | -21.99%-64.74M | ---- |
| Attributable subsidiary (profit) loss | 252.04%54.2M | ---- | 168.60%15.4M | ---- | -65.85%-22.44M | ---- | 76.83%-13.53M | ---- | -34.10%-58.41M | ---- |
| Impairment and provisions: | 34.22%60.67M | --0 | -12.80%45.2M | --0 | 71.15%51.83M | --0 | -73.29%30.29M | --0 | 14,381.74%113.39M | --0 |
| -Impairmen of inventory (reversal) | 95.13%-57K | ---- | 47.67%-1.17M | ---- | -220.34%-2.24M | ---- | --1.86M | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,610.34%13.39M | ---- |
| -Other impairments and provisions | 30.96%60.73M | ---- | -14.24%46.37M | ---- | 90.21%54.07M | ---- | -71.57%28.43M | ---- | --100M | ---- |
| Revaluation surplus: | 156.56%123.48M | --0 | 23.81%-218.34M | --0 | 50.45%-286.57M | --0 | -706.26%-578.38M | --0 | 36.10%-71.74M | --0 |
| -Other fair value changes | 156.56%123.48M | ---- | 23.81%-218.34M | ---- | 50.45%-286.57M | ---- | -706.26%-578.38M | ---- | 36.10%-71.74M | ---- |
| Asset sale loss (gain): | 73.87%-10.64M | --0 | -53.14%-40.7M | --0 | 91.71%-26.58M | --0 | -1,233.23%-320.67M | --0 | 76.64%28.3M | --0 |
| -Loss (gain) from sale of subsidiary company | 31.63%-32.86M | ---- | -267.13%-48.07M | ---- | 96.07%-13.09M | ---- | -5,635.41%-333.06M | ---- | ---5.81M | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 201.94%22.23M | ---- | -31.75%7.36M | ---- | -12.92%10.79M | ---- | -18.30%12.39M | ---- | -5.36%15.16M | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---24.27M | ---- | ---- | ---- | --18.94M | ---- |
| Depreciation and amortization: | 6.64%1.12B | --0 | 21.08%1.05B | --0 | 7.01%865.47M | --0 | 16.95%808.81M | --0 | 9.80%691.6M | --0 |
| -Depreciation | 8.05%1.03B | ---- | 13.98%957.59M | ---- | 5.85%840.11M | ---- | 17.82%793.69M | ---- | 13.41%673.64M | ---- |
| -Amortization of intangible assets | -8.30%82.86M | ---- | 256.26%90.35M | ---- | 67.72%25.36M | ---- | -15.78%15.12M | ---- | -10.86%17.95M | ---- |
| Financial expense | 4.04%25.9M | ---- | 224.78%24.89M | ---- | -37.34%7.66M | ---- | -62.28%12.23M | ---- | -56.38%32.43M | ---- |
| Special items | 156.02%19.2M | ---- | 56.34%-34.28M | ---- | 16.98%-78.52M | ---- | 26.69%-94.59M | ---- | -343.29%-129.03M | ---- |
| Operating profit before the change of operating capital | 4.36%8.52B | --0 | 13.92%8.16B | --0 | 17.08%7.17B | --0 | 18.43%6.12B | --0 | 20.88%5.17B | --0 |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -1,265.49%-583.75M | ---- | 93.07%-42.75M | ---- | -202.60%-617.07M | ---- | 18.09%601.44M | ---- | 182.95%509.32M | ---- |
| Accounts receivable (increase)decrease | -628.86%-3.29B | ---- | 77.52%-451.72M | ---- | -4,314.57%-2.01B | ---- | 95.31%-45.52M | ---- | -67.02%-970.2M | ---- |
| Accounts payable increase (decrease) | 23.93%1.1B | ---- | -41.06%886.61M | ---- | 97.72%1.5B | ---- | 536.31%760.77M | ---- | -90.08%119.56M | ---- |
| prepayments (increase)decrease | 132.83%20.57M | ---- | 71.70%-62.65M | ---- | -407.78%-221.36M | ---- | 187.31%71.92M | ---- | -1,984.99%-82.38M | ---- |
| Cash from business operations | -38.76%5.49B | --0 | 55.10%8.96B | --0 | -25.93%5.78B | --0 | 66.57%7.8B | --0 | 3.94%4.68B | --0 |
| Other taxs | 1.91%-1.31B | ---- | -16.95%-1.33B | ---- | -7.56%-1.14B | ---- | -22.40%-1.06B | ---- | -36.28%-866.83M | ---- |
| Interest paid - operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 56.38%-32.43M | ---- |
| Special items of business | -158.70%-275.07M | ---- | 1,159.77%468.63M | ---- | -115.17%-44.22M | ---- | 577.15%291.57M | ---- | -127.26%-61.11M | ---- |
| Net cash from operations | -45.21%4.18B | -68.98%1.32B | 64.50%7.63B | 55.22%4.26B | -31.20%4.64B | 12.91%2.74B | 78.11%6.74B | 51.95%2.43B | -0.30%3.78B | -3.17%1.6B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 7.16%259.88M | 26.74%124.81M | 32.36%242.53M | 31.29%98.48M | 99.32%183.24M | 183.59%75.01M | 41.48%91.93M | -30.51%26.45M | 14.09%64.98M | 71.67%38.06M |
| Dividend received - investment | -72.05%20M | ---- | 59.03%71.56M | 188.44%129.8M | --45M | --45M | ---- | ---- | --25M | ---- |
| Restricted cash (increase) decrease | ---- | 891.44%41.71M | ---- | ---5.27M | ---- | ---- | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | 456.98%611.54M | 14.65%609.34M | -246.38%-171.31M | 3,118.48%531.49M | -233.74%-49.46M | 64.78%-17.61M |
| Decrease in deposits (increase) | 112.43%232.78M | 122.75%380M | -1,090.39%-1.87B | 1.09%-1.67B | 35.22%-157.36M | -2,948.13%-1.69B | -110.01%-242.9M | 692.82%59.28M | 11.43%2.43B | -141.56%-10M |
| Sale of fixed assets | 731.65%139.99M | -48.74%15.04M | -80.36%16.83M | 671.07%29.35M | 197.21%85.69M | 295.22%3.81M | 254.72%28.83M | -98.84%963K | -47.35%8.13M | 16,823.06%82.92M |
| Purchase of fixed assets | 26.87%-1.62B | 3.54%-785.01M | -57.45%-2.22B | -40.27%-813.86M | ---1.41B | ---580.19M | ---- | ---- | ---- | -60.70%-1.3B |
| Purchase of intangible assets | 47.13%-265.68M | -67.21%-239.11M | -44.26%-502.47M | -74.73%-143M | -75.14%-348.3M | -640.89%-81.84M | -46.88%-198.88M | -74.50%-11.05M | -26.63%-135.4M | -118.28%-6.33M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | 161.97%185.56M | 130.86%185.56M | -3,014.14%-299.43M | -6,725.41%-601.26M | --10.28M | --9.08M |
| Acquisition of subsidiaries | ---- | ---- | ---341.91M | ---301.72M | ---- | ---- | ---- | ---- | -253.05%-507.64M | -155.45%-367.29M |
| Recovery of cash from investments | 38.55%4.53B | 480.55%3.75B | -30.42%3.27B | -175.67%-986.56M | 15.92%4.7B | 242.18%1.3B | 23,773.96%4.05B | -61.15%381.01M | --16.98M | 158.08%980.71M |
| Cash on investment | 49.38%-2.8B | -22.05%-2.5B | -21.57%-5.52B | 2.17%-2.05B | 15.45%-4.54B | 6.41%-2.09B | -58.73%-5.37B | -890.71%-2.23B | 16.17%-3.39B | 88.99%-225.46M |
| Other items in the investment business | 68.82%111.09M | 1,076.51%54.9M | 408.80%65.8M | -99.10%4.67M | 178.91%12.93M | -53.42%519.12M | 98.24%-16.39M | 9,594.62%1.11B | -2,412.27%-931.59M | --11.5M |
| Net cash from investment operations | 108.94%607.27M | 114.92%850.74M | -966.33%-6.8B | -235.61%-5.7B | 70.07%-637.33M | -132.09%-1.7B | 13.34%-2.13B | 9.47%-732.2M | 32.27%-2.46B | 69.25%-808.76M |
| Net cash before financing | 475.89%4.79B | 250.14%2.17B | -79.22%831.08M | -238.60%-1.45B | -13.25%4B | -38.51%1.04B | 247.48%4.61B | 114.85%1.7B | 692.43%1.33B | 180.67%789.75M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | --485.71M | --333.58M | ---- | ---- | 634.78%169M | 1,740.84%184.08M | -18.33%23M | -59.86%10M |
| Refund | 94.38%-27.84M | ---5.1M | -400.72%-495.71M | ---- | ---99M | ---99M | ---- | ---- | 91.38%-70.59M | 69.98%-28.83M |
| Issuing shares | ---- | --59.19M | ---- | ---- | ---- | ---- | ---- | ---- | --1.22B | --1.22B |
| Interest paid - financing | 25.75%-15.99M | -1.44%-9.86M | -181.03%-21.54M | -103.22%-9.72M | 37.34%-7.66M | -3.37%-4.78M | ---12.23M | ---4.63M | ---- | ---- |
| Dividends paid - financing | -29.98%-2.75B | -18.28%-1.23B | -24.32%-2.12B | -14.32%-1.04B | -10.93%-1.7B | -12,891.14%-909.38M | -58.57%-1.54B | 99.27%-7M | -23.37%-968.3M | -22.35%-960.33M |
| Absorb investment income | 910.24%523.99M | 841.09%488.13M | --51.87M | --51.87M | ---- | ---- | ---- | ---- | 412.00%15.36M | --8.15M |
| Issuance expenses and redemption of securities expenses | -1,309.88%-200.36M | -1,309.88%-200.36M | 94.61%-14.21M | ---14.21M | ---263.51M | ---- | ---- | ---- | 3.03%-81.09M | ---81.09M |
| Other items of the financing business | -17.26%171.47M | -87.78%-150.41M | 268.26%207.24M | -27.75%-80.1M | -33.41%-123.17M | -56.71%-62.7M | 94.53%-92.32M | 96.84%-40.01M | -212.15%-1.69B | -206.14%-1.27B |
| Net cash from financing operations | -20.85%-2.3B | -38.24%-1.05B | 13.32%-1.9B | 29.52%-758.22M | -49.33%-2.2B | -912.28%-1.08B | 4.82%-1.47B | 112.10%132.45M | -920.92%-1.55B | -424.77%-1.1B |
| Effect of rate | -65.39%4.89M | -38.10%5.94M | 678.40%14.14M | 458.18%9.59M | -216.33%-2.44M | -402.60%-2.68M | 44.40%2.1M | -23.31%885K | -51.73%1.46M | -43.73%1.15M |
| Net Cash | 331.60%2.49B | 150.95%1.12B | -159.52%-1.07B | -6,674.28%-2.2B | -42.57%1.8B | -101.78%-32.54M | 1,534.49%3.14B | 699.18%1.83B | -1,464.71%-218.83M | 52.43%-305.29M |
| Begining period cash | -11.69%8B | -11.69%8B | 24.80%9.06B | 24.80%9.06B | 76.28%7.26B | 76.28%7.26B | -5.01%4.12B | -5.01%4.12B | 0.44%4.34B | 0.44%4.34B |
| Cash at the end | 31.12%10.49B | 32.99%9.13B | -11.69%8B | -4.97%6.87B | 24.80%9.06B | 21.45%7.22B | 76.28%7.26B | 47.55%5.95B | -5.01%4.12B | 9.65%4.03B |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Deloitte - Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte - Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte - Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte - Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte - Guan Huang Chen Fang Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg